Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Sun Pharma said had a teleconference call with the US Food and Drug Administration (USFDA) regarding a pulmonary embolism (serious adverse events) occurring at the 12 mg dose
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
The USFDA had classified the inspection as "Official Action Indicated" (OAI).
Fully equipped labs with 75-member team set-up and made operational in <100 days
SÜDPACK is setting standards in terms of both performance and sustainability
This plant adds around 60,000 MT of capacity, scaling Jubilant Ingrevia Limited’s overall annual Acetic Anhydride capacity to 210,000 MT
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate with a complete and integrated end-to-end solution
Subscribe To Our Newsletter & Stay Updated
